Show
Sort by
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response : a sub-study of the NEAT001/ANRS143 randomized trial
-
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
-
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia
-
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem : a comparison of eight pharmacokinetic models
-
Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia
-
The antimicrobial resistome in relation to antimicrobial use and biosecurity in pig farming, a metagenome-wide association study in nine European countries
-
Quantitative and qualitative analysis of antimicrobial usage at farm and flock level on 181 broiler farms in nine European countries
-
Quantitative and qualitative analysis of antimicrobial usage patterns in 180 selected farrow-to-finish pig farms from nine European countries based on single batch and purchase data
-
Associations between antimicrobial use and the faecal resistome on broiler farms from nine European countries
-
Evaluation of HIV-1 reservoir levels as possible markers for virological failure during boosted darunavir monotherapy